Condition: Cardiomegaly · Noonan Syndrome · Sponsor: Medical University of Warsaw
The goal of this study is to evaluate the effectiveness of trametinib treatment in patients with Hyperthropic cardiomyopathy and a genetic mutation in the RAS/MAPK pathway.
This description comes directly from the study's public registry record.
Maciej Kołodziej, MD · 22-317-95-37 · maciej.kolodziej@wum.edu.pl
Halszka Kamińska, MD · 22-317-9444 · halszka.kaminska@wum.edu.pl
Always discuss trial participation with your own doctor first.
| Department of Paediatrics, The Medical University of Warsaw, Poland | Warsaw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06555237